Skip to main content

Master of Public Health

The TRUMPET registry: Assessing clinical outcomes and quality of life in patients with castration-resistant prostate cancer and their caregivers.

AUTHORS

Lin DW , Karsh LI , Shevrin DH , Shore ND , Symanowski JT , Quinn DI , Otermat G , Starzyk K , Brown B , Francis PS , Wong EK , Wu J , Wilson SD , Penson DF , . Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 1 20; 34(3_suppl). 241
  • NIHMSID: 8309333

ABSTRACT

241 Background: Patient care in castration-resistant prostate cancer (CRPC) is complex, with varying treatment patterns due to differences in therapies, patient characteristics, and physician practices. The impact of such patterns on clinical outcomes and quality of life (QoL) represent a contemporary medical issue. This study aims to improve the understanding of clinical outcomes and QoL of patients with CRPC and their caregivers.

241 Background: Patient care in castration-resistant prostate cancer (CRPC) is complex, with varying treatment patterns due to differences in therapies, patient characteristics, and physician practices. The impact of such patterns on clinical outcomes and quality of life (QoL) represent a contemporary medical issue. This study aims to improve the understanding of clinical outcomes and QoL of patients with CRPC and their caregivers.

Tags: